Oaktree Acquisition III Life Sciences Stock Price, News & Analysis
Company Description
Oaktree Acquisition III Life Sciences (NASDAQ: OACCU) is a publicly traded shell companies company in the Blank Checks sector.
OACCU stock has gained 4.1% over the past year. Shares last traded at $10.99.
On a trailing twelve-month basis, Oaktree Acquisition III Life Sciences reported net income of $7.3M.
This page provides a comprehensive overview of OACCU stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Oaktree Acquisition III Life Sciences (OACCU) stock last traded at $10.99. Over the past 12 months, the stock has gained 4.1%.
Latest News
Oaktree Acquisition III Life Sciences has 2 recent news articles. Key topics include acquisition, IPO, offering. View all OACCU news →
SEC Filings
Oaktree Acquisition III Life Sciences has filed 10 recent SEC filings, including 4 Form SCHEDULE 13G, 2 Form 10-Q, 2 Form 10-K, 2 Form SCHEDULE 13G/A. The most recent filing was submitted on May 15, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all OACCU SEC filings →
Financial Highlights
operating income reached -$1.2M, and net income was $7.3M. The company generated -$422K in operating cash flow. With a current ratio of 1.19, the company maintains adequate short-term liquidity.
Upcoming Events
Short Interest History
Short interest in Oaktree Acquisition III Life Sciences (OACCU) currently stands at 2.2 thousand shares, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 75.3%. This relatively low short interest suggests limited bearish sentiment. With 180.1 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Oaktree Acquisition III Life Sciences (OACCU) currently stands at 180.1 days, down 58.3% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 843.8% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 4.2 to 1000.0 days.
OACCU Company Profile & Sector Positioning
Oaktree Acquisition III Life Sciences (OACCU) operates in the Shell Companies industry within the broader Blank Checks sector and is listed on the NASDAQ.
Investors comparing OACCU often look at related companies in the same sector, including Aimei Health Technology Co., Ltd (AFJKU), Aldel Financial II (ALDFU), Bayview Acquisition Corp (BAYAU), Cayson Acquisition Corp (CAPNU), and Future Vision II Acquisition Corp (FVNNU). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate OACCU's relative position within its industry.